Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma

Angela Mweempwa; Huiling Xu; Joseph H.A. Vissers; Richard W. Tothill; Andrew D. Pattison; Andrew P. Fellowes; David M. Thomas; Gary Richardson; Rodney J. Hicks; Sean M. Grimmond; Stephen B. Fox; Stephen J. Luen; Jayesh Desai; Benjamin J. Solomon

doi:10.1200/PO.21.00127

Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma

Angela Mweempwa
, Huiling Xu
, Joseph H.A. Vissers
, Richard W. Tothill
, Andrew D. Pattison
, Andrew P. Fellowes
, David M. Thomas
, Gary Richardson
, Rodney J. Hicks
, Sean M. Grimmond
, Stephen B. Fox
, Stephen J. Luen
, Jayesh Desai
, Benjamin J. Solomon

Research output: Contribution to journal › Article › Other › peer-review

Original language	English
Pages (from-to)	1160-1165
Number of pages	6
Journal	JCO Precision Oncology
Volume	5
DOIs	https://doi.org/10.1200/PO.21.00127
Publication status	Published - 15 Jul 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1200/PO.21.00127

Cite this

Mweempwa, A., Xu, H., Vissers, J. H. A., Tothill, R. W., Pattison, A. D., Fellowes, A. P., Thomas, D. M., Richardson, G., Hicks, R. J., Grimmond, S. M., Fox, S. B., Luen, S. J., Desai, J., & Solomon, B. J. (2021). Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma. JCO Precision Oncology, 5, 1160-1165. https://doi.org/10.1200/PO.21.00127

@article{b8b956b4dd964a7ea96723854e73c691,

title = "Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma",

author = "Angela Mweempwa and Huiling Xu and Vissers, \{Joseph H.A.\} and Tothill, \{Richard W.\} and Pattison, \{Andrew D.\} and Fellowes, \{Andrew P.\} and Thomas, \{David M.\} and Gary Richardson and Hicks, \{Rodney J.\} and Grimmond, \{Sean M.\} and Fox, \{Stephen B.\} and Luen, \{Stephen J.\} and Jayesh Desai and Solomon, \{Benjamin J.\}",

year = "2021",

month = jul,

day = "15",

doi = "10.1200/PO.21.00127",

language = "English",

volume = "5",

pages = "1160--1165",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology ",

}

Mweempwa, A, Xu, H, Vissers, JHA, Tothill, RW, Pattison, AD, Fellowes, AP, Thomas, DM, Richardson, G, Hicks, RJ, Grimmond, SM, Fox, SB, Luen, SJ, Desai, J & Solomon, BJ 2021, 'Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma', JCO Precision Oncology, vol. 5, pp. 1160-1165. https://doi.org/10.1200/PO.21.00127

TY - JOUR

T1 - Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma

AU - Mweempwa, Angela

AU - Xu, Huiling

AU - Vissers, Joseph H.A.

AU - Tothill, Richard W.

AU - Pattison, Andrew D.

AU - Fellowes, Andrew P.

AU - Thomas, David M.

AU - Richardson, Gary

AU - Hicks, Rodney J.

AU - Grimmond, Sean M.

AU - Fox, Stephen B.

AU - Luen, Stephen J.

AU - Desai, Jayesh

AU - Solomon, Benjamin J.

PY - 2021/7/15

Y1 - 2021/7/15

UR - https://www.scopus.com/pages/publications/85117712494

U2 - 10.1200/PO.21.00127

DO - 10.1200/PO.21.00127

M3 - Article

C2 - 34994633

AN - SCOPUS:85117712494

SN - 2473-4284

VL - 5

SP - 1160

EP - 1165

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -

Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma

UN SDGs

Access to Document

Other files and links

Cite this